Who invested in Oncothyreon?
Oncothyreon's investors include Iroquois Capital, Cowen Group, Hudson Bay Capital Management, Heights Capital Management and Downsview Capital, and 6 more on record.
United States · Growth startup
3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$65Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by fiercebiotech.comSEC filing: $150K sold, first sale Feb 2011
Reported by ir.oncothyreon.comSEC filing: $15M sold, first sale Sept 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Oncothyreon's investors include Iroquois Capital, Cowen Group, Hudson Bay Capital Management, Heights Capital Management and Downsview Capital, and 6 more on record.
Oncothyreon has raised $65M across 3 rounds since 2010.
Oncothyreon's most recent round was a Growth of $10M in May 2013.
Oncothyreon's largest round on record is $40M (Growth), in Apr 2011.
Oncothyreon's first round on record, in Sept 2010, was backed by Iroquois Capital, Cowen Group and Hudson Bay Capital Management and 8 others.
Oncothyreon's latest named round is a Growth, in May 2013.
Oncothyreon is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.